Medicine and Dentistry
Angiogenesis
100%
Neoplasm
88%
Colorectal Liver Metastasis
71%
Liver Metastasis
63%
Liver Parenchyma
63%
Cyclooxygenase 2 Inhibitor
53%
Tumor Vascularization
53%
Parenchyma
51%
Systematic Review
44%
Amputation
44%
Safety Culture
44%
Surgery
44%
Adverse Event
44%
Ganglioglioma
44%
Cyclooxygenase 2
44%
Patient Safety
44%
Primary Tumor
38%
Metastatic Carcinoma
38%
Hepatocellular Carcinoma
26%
Tumor Progression
25%
Gene Expression
23%
Angiopoietin 2
18%
Angiopoietin 1
18%
Tumor Cell
18%
Glioblastoma
17%
Combination Therapy
17%
Colorectal Carcinoma
14%
Attitude
14%
Tumor Cell Inoculation
11%
Pericyte
11%
Programmed Cell Death
11%
Active Metabolite
11%
Glioma Cell
11%
Huperzine A
11%
Human Umbilical Vein Endothelial Cell
11%
Smooth Muscle Actin
11%
Stromal Cell
11%
In Vitro
11%
Radiation Therapy
8%
Liver Tumor
8%
Tumor Microenvironment
8%
Wound Healing
8%
Antiangiogenic Therapy
8%
Antiangiogenic
8%
Gene Location
7%
Vasculotropin Receptor 1
7%
Angiogenic Factor
7%
Vasculotropin Receptor 2
7%
Vasculotropin
7%
Angiopoietin
7%
Immunology and Microbiology
Angiogenesis
100%
Liver Parenchyma
88%
Tumor Vascularization
59%
Parenchyma
53%
Mouse
48%
Gene Expression
32%
Angiopoietin 1
20%
Angiopoietin 2
20%
Tumor Cell
20%
Apoptosis Rate
17%
Tumor Volume
14%
Blood Vessels
14%
Pericyte
11%
Tumor Cell Inoculation
11%
Smooth Muscle
11%
Metabolite
11%
Glioma Cell
11%
Umbilical Vein Endothelial Cell
11%
Actin
11%
Gene Location
8%
Vasculotropin
8%
Angiogenic Factor
8%
Kinase Insert Domain Receptor
8%
CD31
8%
Vasculotropin A
8%
Angiopoietin
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Keyphrases
Orthotopic Glioma
44%
Patient Safety Culture
44%
Synchronous Liver Metastases
35%
Neuroendocrine Tumor Liver Metastases
33%
Gastroenteropancreatic
33%
Hypervascular
22%
Improvement Efforts
17%
Hospital Survey
17%
Hypovascular
11%
Non-punitive Response to Error
8%
Learning with Errors Problem
8%
Gene Localization
8%
Simultaneous Resection
8%
Cell Injection
7%
Intracranial Glioma
7%
GL261 Glioma
7%
GL261 Cells
7%
Glioma Growth
7%
Organizational Reasons
6%